Beta-alanine Supplementation and CrossFit Performance
Launched by UNIVERSITY OF SASKATCHEWAN · Mar 14, 2023
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Beta-alanine is a nutritional supplement often consumed by people involved in high-intensity sports that involve substantial lactic acidosis. If consumed on a regular basis, it improves muscle buffering capacity and exercise performance during high-intensity moderate-duration events. CrossFit involves competitions that are high in intensity and moderate duration and many elite CrossFit athletes have reported taking beta-alanine as a supplement. It has never however been evaluated in a research study for its affect on CrossFit performance. The purpose of the study is therefore to assess the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum of one year of CrossFit experience and doing CrossFit training at least twice a week
- Exclusion Criteria:
- • Having consumed beta-alanine in the past six months
- • Having changed the dose of any other nutritional supplement within the past month
- • Having suffered a major physical injury in the past six months
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials